Navigation Links
For some diabetics, burden of care rivals complications of disease
Date:9/26/2007

atment may even increase when results from the ongoing ACCORD trial are announced in 2010, said Huang. "This trial may produce evidence for even greater use of medications to try to prevent complications," he said

"Our study results show that taking multiple medications on a routine basis represents a significant burden for many patients," the authors conclude. "Quality of life related to treatments will be likely to improve if we can simplify or modify current treatments through treatment innovations."

Until specialists find ways to do that, Philipson added, "physicians need to be able to spend more time with patients." This includes finding ways to bill appropriately for phone- and web-based interactions. "We also need more ancillary services like psychiatric social workers and diabetes educators to meet with patients," he added. "That could save the health care system a ton of money, even without developing new drugs or treatments. But we have to do that as well."


'/>"/>

Contact: John Easton
John.Easton@uchospitals.edu
773-702-6241
University of Chicago Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Burden of lung disease
2. Suggestions to reduce global heart disease burden
3. Poor Health of people in Central Goldfields Shire, reports The Victorian Burden of Disease
4. Study Finds ER Not Overburdened By Uninsured & Immigrants
5. Dementia Care Intervention Eases Burden for Families
6. America Sags Under Burden of Neurological Diseases
7. Increased Depression, Burden, Reported in Family Caregivers of ALS Patients
8. Refugees No Burden On Health System
9. Hospital Infections Like MRSA Affect The New Arrivals More
10. Rivals of the South Dakota Law Says No to Abortion
11. Coronary stent leads to complications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)...USTON - Gefitinib, the once-promising drug formerl...cer, also known as Iressa, enhanced the effectiven...fic types of metastatic breast cancer, according t...The University of Texas M. D. Anderson Cancer Cent...t the first positive study for Iressa in breast ca...
(Date:5/16/2008)...TON, May 16 /PRNewswire-USNewswire/ -- Behavioral ...ponding to the needs of the millions,of Americans ...ce use,conditions each year, according to the late...Psychiatric Health Systems (NAPHS) released today....nct views of behavioral,healthcare delivery. One c...
(Date:5/16/2008)...y announces appointment of Nomura Code Securities ... sole broker, NEW YORK, May 16 /PRNewswire-FirstC...l Investments, Inc. (Amex: MGT ) (the "Company"),...uter-Aided Detection (CAD) and,image analysis soft...nosis,of disease, today announced the appointment ...
(Date:5/16/2008)...T, Conn., May 16 /PRNewswire/ -- Tao Formulations ...opause Relief Formula, at the Internal,Medicine 20... product is,the culmination of years of research t...gen-free) alternative for relieving menopausal sym... board certified obstetrician,and gynecologist, fo...
Breaking Medicine News(10 mins):Health News:Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy 2Health News:Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy 3Health News:New NAPHS Annual Survey Tracks Behavioral Treatment Trends 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 3Health News:Tao Formulations Announces the Official Launch of Tao Harmony - Menopause Relief Formula 2
...(Jawaharlal Institute of Postgraduate Medical Coll...day //long strike to protest against the governmen...her educational institutes. A spokesman of the As...t they had submitted a memo to the government to h...
...triking medicos to immediately call off their 20-d...and resume work within three days. The court - whi... also warned that strong action will be taken if i...ed. "We direct that all strikes, protests and dem...
...eat diabetic nerve damage has shown promising resu...s// of the University of Manchester, when injected...ular gene responsible to prevent nerve damage in h...he positive preclinical results – reported in the ...
...Centrally administered Jawaharlal Nehru Institute ...IPMER) // in Pondicherry today began a 48-hour lon...te educational institutions. A batch of resident ...ast inside the campus urging the Centre to review ...
Other Medicine News:Health News:New Gene Therapy Treats Diabetic Neuropathy 2
(Date:5/15/2008)...ay 15 /- Eisai Corporation of North,A...al data abstracts about,compounds in the company,s...cal oncology research have been accepted for prese... Society of Clinical Oncology (ASCO),taking place...variety of abstracts on Eisai marketed products an...
(Date:5/15/2008)...ical Data from Prostate, Colorectal and Ovarian ...to Hold Investor Event on Sun., June 1 with Oncolo... /- Poniard,Pharmaceuticals...ny focused,on oncology, today announced that the C...s of picoplatin, in various tumor types and combin...
(Date:5/15/2008)...5 /- Schering-Plough,Corpor...ence and treatment of,chronic hepatitis C virus (H...ral clinical studies with PEGINTRON(TM) (peginterf...ination therapy, as well as boceprevir, the,compan...ill be presented at,the 39th annual Digestive Dise...
(Date:5/15/2008)...ULOUSE, France, May 15 /- Cerenis,The...tical company,developing HDL-related compounds for...eases, today announced that it has completed a Pha...y,s lead product candidates.,CER-002 is a peroxiso...ecific agonist in development for the treatment of...
Breaking Medicine Technology:Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 2Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 3Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 4Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 5Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 6Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 7Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 8Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 2Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 3Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 4Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2Kaiser Permanente Study Shows Newer Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk 2671 1Kaiser Permanente Study Shows Newer Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk 2671 2Kaiser Permanente Study Shows Newer Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk 2671 3Kaiser Permanente Study Shows Newer Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk 2671 4Kaiser Permanente study shows link between caffeine and miscarriage 9813 1Kaiser Permanente study shows link between caffeine and miscarriage 9813 2Kaiser Permanente study shows link between caffeine and miscarriage 9813 3Pros cons of drug proven to prevent prostate cancer should be considered researchers recommend 9810 1Pros cons of drug proven to prevent prostate cancer should be considered researchers recommend 9810 2NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 1NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 2NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 3NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 4NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 5
...gned to provide functional management of stress fr...able fractures of the lower leg.,The Leg Brace fea...patented Duplex™ aircell system. This exclus...ng aircells, distal and proximal, that provide sup...
...s available with optional hot and cold therapy Gel...roviding cold therapy to reduce swelling and /or h...covery.,To order hot and cold therapy gel pad, pla...o fit., ,Our Patented Formfit 3-dimensional moldi...
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
FREEDOM® Memory Thumb Spica lets you make a custom splint in minutes. Immerese in 160 F water until pliable, and remove. Amazingly, it maintains its shape and is ready to be precisely, profession
Medicine Products: